Keyphrases
Congestive Heart Failure
100%
Patients with Heart Failure
100%
Matrix Metalloproteinases
100%
Plasma Matrix
100%
Heart Failure Patients
77%
Matrix metalloproteinase-9 (MMP-9)
66%
TNF Receptor 1 (TNFR1)
55%
Nine-level
33%
Matrix metalloproteinase-2 (MMP-2)
33%
Tumor Necrosis Factor-α
22%
Left Ventricular Ejection Fraction
22%
Plasma Parameters
22%
TNF Receptor 2 (TNFR2)
22%
Matrix metalloproteinase-1 (MMP-1)
22%
Plasma Profile
22%
MMP-8
22%
Absolute Reductions
11%
Age-matched
11%
Enzyme-linked Immunosorbent Assay (ELISA)
11%
Prognostic Significance
11%
Matrix Metalloproteinase Inhibitors
11%
Cytokine Activity
11%
Serial Measurements
11%
Remodeling Process
11%
Assay Kit
11%
Background Change
11%
LV Remodeling
11%
Reduced Matrix
11%
Biochemistry, Genetics and Molecular Biology
Matrix Metalloproteinase
100%
Blood Plasma
100%
Gelatinase B
60%
MMP9
60%
Gelatinase A
30%
MMP2
30%
Cytokine
20%
Tumor Necrosis Factor
20%
Blood Level
20%
Heart Left Ventricle Ejection Fraction
20%
Interstitial Collagenase
20%
Neutrophil Collagenase
20%
Enzyme
10%
Tumor Necrosis Factor Receptor
10%
Medicine and Dentistry
Congestive Heart Failure
100%
Matrix Metalloproteinase
100%
Gelatinase B
60%
Gelatinase A
30%
Cytokine
20%
Tumor Necrosis Factor
20%
Heart Left Ventricle Ejection Fraction
20%
Tumor Necrosis Factor Receptor 2
20%
Interstitial Collagenase
20%
Neutrophil Collagenase
20%
Tumor Necrosis Factor Receptor
10%
In Vitro
10%
Enzyme Linked Immunosorbent Assay
10%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Matrix Metalloproteinase
100%
Gelatinase B
60%
Gelatinase A
30%
Tumor Necrosis Factor
20%
Cytokine
20%
Tumor Necrosis Factor Receptor 2
20%
Interstitial Collagenase
20%
Neutrophil Collagenase
20%
Tumor Necrosis Factor Receptor
10%
Enzyme-Linked Immunosorbent Assay
10%